Use access key #2 to skip to page content.
$5.56 0.00 (0.00%)
10/13/2008 4:00 PM

Bioenvision, Inc. (BIVN.DL)

CAPS Rating:
No stars

A biopharmaceutical company, which focuses upon the acquisition, development and marketing of compounds and technologies for the treatment of cancer.

View All Commentary (BIVN.DL)

Recs

0

Avatar Dudeone (73.84) Submitted: 5/14/07 4:37 PM : Outperform Start Price: $3.29 BIVN.DL Score: 69.10

Clofabarine in EU/ROW will make them attractive for takeover I suspect. Watch it kick in a few months time

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links